After several years of extensive studies, Maitake Products, Inc. has announced a new product based on the newly discovered active fraction of Maitake, Grifron SX-fraction
. Studies have been conducted at Georgetown University and NY Medical College, with results showing SX-Fraction to posses a potent ability to support maintenance of healthy blood sugar levels
Grifron, SX-Fraction, the only standardized extract to contain the active SX-fraction, is launched as the first dietary supplement of its class that specifically addresses its beneficial role in Syndrome X as a part of a diet to help maintain healthy blood sugar and blood pressure levels. (This sinister-sounding syndrome; also known as Insulin Resistance Syndrome, Metabolic Syndrome, Fat Gut Syndrome or Deadly Quartet; is a cluster of symptoms that may include the following:
- obesity (excessive fat tissue in the abdominal region)
- hyperlipidemia (high triglycerides and low HDL cholesterol)
- high blood pressure
- glucose intolerance (higher blood glucose level than normal)
Syndrome X can lead to life-threatening diseases including type II diabetes, hypertension and heart disease. More importantly, people with Syndrome X are also more likely than others to die from cardiovascular disease. It is said that 50~70 million Americans are supposed to have Syndrome X, and most of whom are unaware of this serious problem.
For general support for healthy blood sugar maintenance, take one tablet within 30 minutes after each meal.One tablets three times a day. For maximum impact, you may double or triple the general dose.
Ingredients: Every one tablet contains 100mg of Maitake standardized extract (SX-fraction 18%) and 250 mg of Maitake fruit body powder. It contains NO sugar, yeast, mold, artificial colors, dairy foods, chemical pesticides or fertilizers.
SX-Fraction is a trademark applied for registration by Maitake Products, Inc. "SX" stands for both "Syndrome X" and "Super X", since SX-fraction is developed as an improved version of X-fraction which is also patented by Maitake Products, Inc. (U.S. Patent #5,773,426).